Company / Return on Assets (ROA)
Bionano Genomics, Inc. Return on Assets (ROA) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-35.9%
FY2025
5-year range
-146.1% / -19.2%
FY2021-FY2025
Trend
+75.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) returned to growth in FY2025 after 3 years of decline, reaching -35.9%.
Based on SEC 10-K filings.
-35.9% in FY2025 with a 5-year CAGR of +32.1%.
Improved from -108.4% to -35.9% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +7.3pp
- 5-Year Change
- +32.1pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 75.4% year-over-year.
- Peak return on assets (roa) was recorded in FY2021.
- Lowest return on assets (roa) in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -8.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -35.9% | +75.4% |
| FY2024 | -146.1% | -34.7% |
| FY2023 | -108.4% | -151.5% |
| FY2022 | -43.1% | -124.5% |
| FY2021 | -19.2% | +71.8% |
| FY2020 | -68.0% | +31.1% |
| FY2019 | -98.7% | -32.4% |
| FY2018 | -74.6% | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 22, 2026